We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alessandra Ferrajoli

Alessandra Ferrajoli MD

Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dr. Ferrajoli is an academic hematologist/oncologist practicing in the Leukemia Department at the University of Texas, MD Anderson since 1998. Her main area of interest includes the treatment and biology of chronic lymphocytic leukemia and its... variants, and treatment of elderly patients with acute and chronic leukemia. In these fields Dr. Ferrajoli has authored and co-authored more than two hundred and fifty publications in peer reviewed journals. Dr. Ferrajoli serves on numerous journal editorial boards and grant proposal study sessions for several US and European Agencies. Dr. Ferrajoli is a member of professional societies such the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), International Society of Geriatric Oncology (SIOG), the European Society for Medical Oncology (ESMO) and the European Hematology Association (EHA).